TMEM106B C-terminal peptide abundance

Biomarker

1 paper2 findings

  • Humans1

Upstream

1

TMEM106BHABHAPLOTYPE

upin humans1downin humans1

1 study
  1. TMEM106BHABHAPLOTYPE increases TMEM106B C-terminal peptide abundance in humans (1.16-fold higher).

    “the risk‐increasing HAB is associated with 1.16‐fold higher abundance”

    Humansrelative to neutral HaB combinationtemporal cortex

    Fine‐mapping of the TMEM106B locus reveals four haplotypes that are differentially associated with risk for neurodegeneration

    AAIC 2025 abstract24 Dec 2025

  2. TMEM106BHABHAPLOTYPE decreases TMEM106B C-terminal peptide abundance in humans (1.1-fold lower).

    “the protective Hab is associated with 1.1‐fold lower TMEM106B C‐terminal peptide abundance”

    Humansrelative to neutral HaB combinationtemporal cortex

    Fine‐mapping of the TMEM106B locus reveals four haplotypes that are differentially associated with risk for neurodegeneration

    AAIC 2025 abstract24 Dec 2025

More on TMEM106BHABHAPLOTYPE

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months